Loading insider details...
Beta
Latest Form 4 (Aug 21, 2026): Sale of 1,697 ARQT shares, $45.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 1,697 | $45.8K |
| Aug 14, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Exercise/Conversion | 8,300 | $30.2K |
| Aug 6, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 955 | $24.9K |
| May 13, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 222 | $4.7K |
| May 6, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 684 | $16.1K |
| Mar 4, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 16,750 | n/a |
| Feb 5, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 3,675 | $93.7K |
| Jan 7, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 2,490 | $72.2K |
| Jan 2, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 541 | $15.6K |
| Dec 17, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Exercise/Conversion | 11,500 | $41.9K |